SUBSCRIBE
SUBSCRIBE

Astria Therapeutics

NEWS
Business
BioSpace Movers & Shakers: Astria, Apertura, CytoDyn, IN8bio & More Make Big Moves
New leaders and top executive roles were selected to guide biopharma and life science companies from Apertura Gene Therapy to CytoDyn, Vaccentis AG, Suvoda LLC, IN8bio and more.
July 14, 2022
 · 
9 min read
 · 
Alex Keown
JOBS
IN THE PRESS
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - June 04, 2024
June 4, 2024
 · 
1 min read
Genetown
Astria Therapeutics to Present at Upcoming Jefferies Healthcare Conference - May 30, 2024
May 30, 2024
 · 
1 min read
Genetown
Astria Therapeutics to Present at Upcoming Eastern Allergy Conference - May 24, 2024
May 24, 2024
 · 
1 min read
Genetown
Astria Therapeutics to Present at Upcoming European Academy of Allergy and Clinical Immunology Congress
May 23, 2024
 · 
1 min read
Business
Astria Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
May 9, 2024
 · 
13 min read
Genetown
Astria Therapeutics to Present at Upcoming Society for Investigative Dermatology Annual Meeting
May 8, 2024
 · 
1 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 02, 2024
May 2, 2024
 · 
1 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 03, 2024
April 3, 2024
 · 
1 min read
Drug Development
Astria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAE
March 25, 2024
 · 
12 min read
Genetown
Astria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - March 05, 2024
March 5, 2024
 · 
1 min read
Load More